Which brand names are associated with Lithium IR tablets?

Lithium IR tablets are primarily associated with brand names that reflect their active ingredient and formulation. Eskalith and Lithotabs are recognized as effective formulations of lithium used in the management of mood disorders, particularly bipolar disorder. Eskalith is specifically a brand name of lithium carbonate designed for immediate-release, and Lithotabs refers to the tablet form of lithium, also marketed for immediate-release use.

The other choices contain brand names that may not correctly correspond with the specific formulations of lithium IR tablets. For example, while Lithobid is a brand of lithium cation, it denotes a sustained-release formulation rather than immediate-release, making it inapplicable in this context. Understanding the distinctions between immediate-release and sustained-release formulations is crucial for accurate identification of medications, especially in the management of psychiatric disorders where dosing and release rates are vital in ensuring therapeutic efficacy.